FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder

By Sep 17, 2026

Regulatory Approvals — FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder Fierce Pharma

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 17, 2026.

By

Regulatory Approvals

FDA Clears Robotic System for Endoscopic Procedures in the Colon

Sep 17, 2026

Regulatory Approvals

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

Sep 17, 2026

Regulatory Approvals

FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC

Sep 17, 2026

FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder

By

Financial News For All

Workers at public Oregon universities vote to strike – Lookout Eugene

National Bank Regulator Begins Round of Layoffs, Union Says (1)

Oregon university workers vote to strike across the state – The Register

FDA Clears Robotic System for Endoscopic Procedures in the Colon

FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder

By

Related Post

FDA Clears Robotic System for Endoscopic Procedures in the Colon

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

FDA Approves sNDA for Taletrectinib in ROS1+ NSCLC

Financial News For All

Workers at public Oregon universities vote to strike – Lookout Eugene

National Bank Regulator Begins Round of Layoffs, Union Says (1)

Oregon university workers vote to strike across the state – The Register

FDA Clears Robotic System for Endoscopic Procedures in the Colon